Presence of simian virus 40 DNA sequences in diffuse large B-cell lymphomas in Tunisia correlates with aberrant promoter hypermethylation of multiple tumor suppressor genes
Hachana, Mohamed Ridha ; Université de Liège - ULiège > Département des sciences cliniques > GIGA-R:Immunopath. - Maladies infect. et médec. inter. gén.
Sriha, Badreddine
Mokni, Moncef
Korbi, Sadok
Language :
English
Title :
Presence of simian virus 40 DNA sequences in diffuse large B-cell lymphomas in Tunisia correlates with aberrant promoter hypermethylation of multiple tumor suppressor genes
Publication date :
15 December 2007
Journal title :
International Journal of Cancer
ISSN :
0020-7136
eISSN :
1097-0215
Publisher :
Wiley Liss, Inc., New York, United States - New York
Butel JS, Lednicky JA. Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst 1999;91:119-34.
Butel JS. Increasing evidence for involvement of SV40 in human cancer. Dis Markers 2001;17:167-72.
Stratton K, Almario DA, McCormick MC, eds. Immunization safety review: SV40 contamination of polio vaccine and cancer. Washington, DC: The National Academies Press, 2003.
Vilchez RA, Butel JS. Emergent human pathogen simian virus 40 and its role in cancer. Clin Microbiol Rev 2004;17:495-508.
Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL. DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 1992;326:988-93.
Lednicky JA, Garcea RL, Bergsagel DJ, Butel JS. Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. Virology 1995;212:710-17.
Carbone M, Pass HI, Rizzo P, Marinetti M, Di Muzio M, Mew DJ, Levine AS, Procopio A. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 1994;9:1781-90.
Lednicky JA, Stewart AR, Jenkins JJ, Finegold MJ, Butel JS. SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes. Int J Cancer 1997;72:791-800.
Galateau-Salle F, Bidet P, Iwatsubo Y, Gennetay E, Renier A, Letourneux M, Pairon JC, Moritz S, Brochard P, Jaurand MC, Freymuth F. SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma, and non-malignant pulmonary diseases. J Pathol 1998;184:252-7.
Gamberi G, Benassi MS, Pompetti F, Ferrari C, Ragazzini P, Sollazzo MR, Molendini L, Merli M, Magagnoli G, Chiesa F, Gobbi AG, Powers A, et al. Presence and expression of the simian virus-40 genome in human giant cell tumors of bone. Genes Chromosomes Cancer 2000;28:23-30.
Pacini R, Vivaldi A, Santoro M, Fedele M, Fusco A, Romei C, Basolo F, Pinchera A. Simian virus 40-like DNA sequences in human papillary thyroid carcinomas. Oncogene 1998;16:665-9.
Vilchez RA, Madden CR, Kozinetz CA, Halvorson SJ, White ZS, Jorgensen JL, Finch CJ, Butel JS. Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002;359:817-23.
Shivapurkar N, Harada K, Reddy J, Sceuermann RH, Xu Y, McKenna RW, Milchgrub S, Kroft SH, Feng Z, Gazdar AF. Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 2002;359: 851-2.
Nakatsuka S, Liu A, Dong Z, Nomura S, Takakuwa T, Miyazato H, Aozasa K, Osaka Lymphoma Study Group. Simian virus 40 sequences in malignant lymphomas in Japan. Cancer Res 2003;63:7606-8.
Shivapurkar N, Takahashi T, Reddy J, Zheng Y, Stastny V, Collins R, Toyooka S, Suzuki M, Parikh G, Asplund S, Kroft SH, Timmons C, et al. Presence of simian virus 40 DNA sequences in human lymphoid and hematopoietic malignancies and their relationship to aberrant promoter methylation of multiple genes. Cancer Res 2004;64:3757-60.
Chen PM, Yen CC, Yang MH, Poh SB, Hsiao LT, Wang WS, Lin PC, Lee MY, Teng HW, Bai LY, Chu CJ, Chao SC, et al. High Prevalence of SV40 Infection in patients with nodal Non-Hodgkin's lymphoma but not acute leukemia independent of contaminated polio vaccines in Taiwan. Cancer Invest 2006;24:223-8.
Heinsohn S, Golta S, Kabisch H, zur Stadt U. Standardized detection of Simian virus 40 by real-time quantitative polymerase chain reaction in pediatric malignancies. Haematologica 2005;90:95-100.
Daibata M, Nemoto Y, Kamioka M, Imai S, Taguchi H. Simian virus 40 in Japanese patients with lymphoproliferative disorders. Br J Haematol 2003;121:190-1.
Meneses A, Lopez-Terrada D, Zanwar P, Killen DE, Monterroso V, Butel JS, Vilchez RA. Lymphoproliferative disorders in Costa Rica and simian virus 40. Haematologica 2005;90:1635-42.
David H, Mendoza S, Konishi T, Miller CW. Simian virus 40 is present in human lymphomas and normal blood. Cancer Lett 2001; 162:57-64.
MacKenzie J, Wilson KS, Perry J, Gallagher A, Jarrett RF. Association between simian virus 40 DNA and lymphoma in the United kingdom. J Natl Cancer Inst 2003;95:1001-3.
Schuler F, Dolken SC, Hirt C, Dolken MT, Mentel R, Gurtler LG, Dolken G. No evidence for simian virus 40 DNA sequences in malignant non-Hodgkin lymphomas. Int J Cancer 2006;118:498-504.
Sui LF, Williamson J, Lowenthal RM, Parker AJC. Absence of simian virus 40 (SV40) DNA in lymphoma samples from Tasmania, Australia. Pathology 2005;37:157-9.
White MK, Khalili K. Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. Virology 2004; 324:1-16.
Soejima K, Fang W, Rollins BJ. DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras. Oncogene 2003;22:4723-33.
Gazdar AF, Butel JS, Carbone M. SV40 and human tumours: myth, association or causality? Nat Rev Cancer 2002;2:957-64.
Esteller M. Relevance of DNA methylation in the management of cancer. Lancet Oncol 2003;4:351-8.
Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002;21:5427-40.
Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Haematopoietic and Lymphoid Tissues. Lyon: International Agency for Research on Cancer (IARC) Press, 2001.
Man Y, Moinfar F, Bratthauer GL, Kuhls EA, Tavassoli FA. An improved method for DNA extraction from paraffin sections. Pathol Res Pract 2001;197:635-42.
Lednicky JA, Butel JS. Consideration of PCR methods for the detection of SV40 in tissue and DNA specimens. Dev Biol Stand 1998;94:155-64.
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239;487-91.
Toyooka S, Pass HI, Shivapurkar N, Fukuyama Y, Maruyama R, Toyooka KO, Gilcrease M, Farinas A, Minna JD, Gazdar AF. Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma. Cancer Res 2001;61:5727-30.
Suzuki M, Toyooka S, Shivapurkar N, Shigematsu H, Miyajima K, Takahashi T, Stastny V, Zern AL, Fujisawa T, Pass HI, Carbone M, Gazdar AF. Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection. Oncogene 2005; 24:1302-8.
Toyooka S, Carbone M, Toyooka KO, Bocchetta M, Shivapurkar N, Minna JD, Gazdar AF. Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells. Oncogene 2002;2:4340-4.
Weegen S, Bayer TA, Von Deimling A, Reifenberger G, Von Schweinitz D, Wiestler OD, Pietsch T. Low frequency of SV40, JC and BK Polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas. Brain Pathol 2000;10:85-92.
Shah KV. Does SV40 infection contribute to the development of human cancers? Rev Med Virol 2000;10:31-43.
Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR. a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-6.
Fan X, Inda MM, Tunon T, Castresana JS. Improvement of the methylation specific PCR technical conditions for the detection of p16 promoter hvpermethylation in small amounts of tumor DNA. Oncol Rep 2002;9:181-3.
Singal R, Ferdinand L, Reis IM, Schlesselman JJ. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease. Oncol Rep 2004;12:631-637.
Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB, Herman JG. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res 2000;60:129-33.
Katzenellenbogen RA, Baylin SB, Herman JG. Hypermethylation of the DAP-kinase CpG island is a common alternation in B-cell malignancies. Blood 1999;93:4347-53.
Esteller M. Sparks A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Gonzalez S, Tarafa G, Sidransky D, Meltzer SJ, Baylin SB, Herman JG. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 2000;60:4366-71.
Oka T, Ouchida M, Koyama M, Ogama Y, Takada S, Nakatami Y, Tanaka T, Yoshino T, Hayashi K, Ohara N, Kondo E, Takahashi K, et al. Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas. Cancer Res 2002;62: 6390-4.
Corn PG, Heath RH, Fogt F, Forastiere AA, Herman JG, Wu T. Frequent hypermethylation of the 5′ CpG island of E-Cadherin in esophageal adenocarcinomas. Clin Cancer Res 2001;7:2765-9.
Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res 1998;58:4515-18.
Amatya VJ, Naumann U, Weller M, Ohgaki H. TP53 promoter methylation in human gliomas. Acta Neuropathol 2005;110:178-84.
Simpson DJ, Hibberts NA, McNicol AM, Clayton RN, Farrell WE. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island. Cancer Res 2000;60:1211-16.
Chim CS, Wong ASY, Kwong YL. Absence of p300 gene promoter methylation in acute leukemia. Cancer Genet Cytogenet 2004;150: 164-7.
Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999;59:793-7.
Agathanggelou A, Dallol A, Zochbauer-Muller S, Morrissey C, Honorio S, Hesson L, Martinsson T, Fong KM, Kuo MJ, Yuen PW, Maher ER, Minna JD, et al. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Oncogene 2003;22:1580-8.
House MG, Guo MZ, Efron DT, Lillemoe KD, Cameron JL, Syphard JE, Hooker CM, Abraham SC, Montgomery EA, Herman JG, Brock MV. Tumor suppressor gene hypermethylation as a predictor of gastric stromal tumor behavior. J Gastrointest Surg 2003;7:1004-14.
Vilchez RA, Kozinetz CA, Butel JS. Conventional epidemiology and the link between SV40 and human cancers. Lancet Oncol 2003;4:188-91.
Esteller M. Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg. Clinical Immunology 2003;109:80-8.
Shah KV. SV40 and human cancer: a review of recent data. Int J Cancer 2007;120:215-23.
Vilchez RA, Kozinetz CA, Arrington AS, Madden CR, Butel JS. Simian virus 40 in human cancers. Am J Med 2003;114:675-84.
Minor P, Pipkin P, Jarzebek Z, Knowles WA. Studies of neutralizing antibodies to SV40 in human sera. J Med Virol 2003;70:490-5.
Coles BF, Kadlubar FF. Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs? Biofactors 2003;17:115-30.
Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999;96:8681-6.
Lanagan JM. Host epigenetic modifications by oncogenic viruses. Br J Cancer 2007;96:183-8.
Li HP, Leu YW, Chang YS. Epigenetic changes in virus-associated human cancers. Cell Res 2005;15:262-71.
